Measures blood markers of nerve damage and inflammation in Parkinson's disease
Collects blood samples from adults with Parkinson's disease at different stages.
Key facts
- Who runs it
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Where
- Roma, ItalySee the site
- Trial code
- Registry title
- Serum Biomarkers in Parkinson's Disease at Different Stages
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 10 Feb 2022
- Expected to end
- 30 Nov 2027
- Type of study
- Interventional
- Treatments tested
- blood sample
- Record updated
- 15 March 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Parkinson's disease of unknown cause, at different stages of the disease. It measures markers in blood samples.
- Age
- 18 to 80 years
- Sex
- All sexes can join.
- Disease stage
- Idiopathic Parkinson's disease diagnosed by Movement Disorders Society (MDS) criteria. Different disease stages are studied.
Main reasons for not taking part
- Pregnant women
- Inflammatory or autoimmune diseases
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients diagnosed with idiopathic PD according to Movement Disorders Society (MDS) criteria
- Age: 18-80 years
- Signature of informed consent to participate in this study
Who cannot take part
- Inflammatory or autoimmune diseases
- Women pregnant
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in Italy
- Flavia TorlizziRoma, ItalyContact: Flavia TorlizziTaking people
About the trial
What the trial wants to find out
* Determine clinical characteristics of parkinsonian patients in various stages of disease; * Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease. * Measure vesicular neurodegeneration, synaptic and inflammation biomarkers
The group in the trial
- BiomarkersTreatment being tested
Treatment: blood sample
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Serum Biomarkers in Parkinson's Disease at Different Stages
- Plain-language title
- Measures blood markers of nerve damage and inflammation in Parkinson's diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05769699, who can take part
- Record updated
- 15 March 2023